Mitigation of COVID-19 at the 2021 National Collegiate Athletic Association Men's Basketball Tournament

dc.contributor.authorDixon, Brian E.
dc.contributor.authorFadel, William F.
dc.contributor.authorDuszynski, Thomas J.
dc.contributor.authorCaine, Virgina A.
dc.contributor.authorMeyer , Joeseph F.
dc.contributor.authorSaysana , Michele
dc.contributor.departmentEpidemiology, Richard M. Fairbanks School of Public Health
dc.date.accessioned2024-05-07T20:25:42Z
dc.date.available2024-05-07T20:25:42Z
dc.date.issued2022-11-10
dc.description.abstractBackground Data are lacking regarding the risk of viral SARS-CoV-2 transmission during a large indoor sporting event involving fans utilizing a controlled environment. We sought to describe case characteristics, mitigation protocols used, variants detected, and secondary infections detected during the 2021 National Collegiate Athletic Association (NCAA) Men’s Basketball Tournament involving collegiate athletes from across the U.S. Methods This retrospective cohort study used data collected from March 16 to April 3, 2021, as part of a closed environment which required daily reverse transcription-polymerase chain reaction (RT-PCR) testing, social distancing, universal masking, and limited contact between tiers of participants. Nearly 3000 players, staff, and vendors participated in indoor, unmasked activities that involved direct exposure between cases and noninfected individuals. The main outcome of interest was transmission of SARS-CoV-2 virus, as measured by the number of new infections and variant(s) detected among positive cases. Secondary infections were identified through contact tracing by public health officials. Results Out of 2660 participants, 15 individuals (0.56%) screened positive for SARS-CoV-2. Four cases involved players or officials, and all cases were detected before any individual played in or officiated a game. Secondary transmissions all occurred outside the controlled environment. Among those disqualified from the tournament (4 cases; 26.7%), all individuals tested positive for the Iota variant (B.1.526). All other cases involved the Alpha variant (B.1.1.7). Nearly all teams (N = 58; 85.3%) reported that some individuals had received at least one dose of a vaccine. Overall, 17.9% of participants either had at least one dose of the vaccine or possessed documented infection within 90 days of the tournament. Conclusion In this retrospective cohort study of the 2021 NCAA Men’s Basketball Tournament closed environment, only a few cases were detected, and they were discovered in advance of potential exposure. These findings support the U.S. Centers for Disease Control and Prevention (CDC) guidelines for large indoor sporting events during the COVID-19 pandemic.
dc.eprint.versionFinal published version
dc.identifier.citationDixon, B. E., Fadel, W. F., Duszynski, T. J., Caine, V. A., Meyer, J. F., & Saysana, M. (2022). Mitigation of COVID-19 at the 2021 National Collegiate Athletic Association Men’s Basketball Tournament. BMC Public Health, 22(1), 2061. https://doi.org/10.1186/s12889-022-14547-1
dc.identifier.urihttps://hdl.handle.net/1805/40537
dc.language.isoen_US
dc.publisherSpringer
dc.relation.isversionof10.1186/s12889-022-14547-1
dc.relation.journalBMC Public Health
dc.sourcePublisher
dc.subjectCOVID-19 pandemic
dc.subjectSARS-CoV-2 virus
dc.subjectPublic Health Surveillance
dc.subjectCommunicable disease control
dc.subjectInfectious disease transmission
dc.subjectBasketball
dc.subjectSports
dc.subjectAthletes
dc.titleMitigation of COVID-19 at the 2021 National Collegiate Athletic Association Men's Basketball Tournament
dc.typeArticle
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Dixon2022Mitigation-CCBY.pdf
Size:
1.32 MB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.99 KB
Format:
Item-specific license agreed upon to submission
Description: